Effectiveness of a booster dose of COVID-19 vaccines during an outbreak of SARS-CoV-2 Omicron BA.2.2 in China: A case–control study

Effectiveness of a booster dose of COVID-19 vaccines during an outbreak of SARS-CoV-2 Omicron BA.2.2 in China: A case–control study

Real-world evidence on the effectiveness of COVID-19 vaccines marketed in China against the Omicron BA.2.2 variant remains scarce. A case–control study was conducted to estimate the vaccine effectiveness (VE) of COVID-19 vaccines marketed in China (inactivated vaccines, an Ad5-nCoV vaccine, and a re...

Full description

Bibliographic Details
Main Authors: Xiaqing Zhang, Yao Wang, Chengyang Hu, Pengpeng Xu, Liguo Ma, Lei Liu, Jie Sun, Yang Liu, Hui Yang, Fan Pan, Jieying Hu, Chengsong Cao, Kai Cheng, Dawei Gao, Yong Lyu, Wei Qin
Format: Article
Language:English
Published: Taylor & Francis Group 2023-01-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
covid-19 vaccines
omicron
vaccine effectiveness
inactivated vaccine
ad5-ncov vaccine
recombinant protein vaccine
Online Access:http://dx.doi.org/10.1080/21645515.2023.2194189

Internet

http://dx.doi.org/10.1080/21645515.2023.2194189

Similar Items